Sector Axsome Therapeutics, Inc.

Aandelen

AXSM

US05464T1043

Farmaceutische producten

Beurs gesloten - 22:00:00 20-10-2026 Variatie 5 dagen Verschil t.o.v. 1 jan (%)
159,58 USD +2,42% Intraday-grafiek van Axsome Therapeutics, Inc. +2,09% -12,63%
Belangrijkste concurrenten
Verschil (%) Varia. 5d. Evolutie 1 maand Evolutie 3 maanden Var. 1 jan Varia. 1j. Varia. 3j. Varia. 5j. Varia. 10j. Kap.($)
+2,42%+2,09%-22,34%-28,00%-12,63%+21,26%+148,37%+280,77%+2.083,04% 8,16 mld.
+3,49%+10,04%+10,20%+11,92%+19,45%+58,68%+119,56%+426,69%+1.530,25% 1.106 mld.
+2,19%+4,32%-3,75%+4,24%+25,32%+33,88%+69,52%+58,36%+125,79% 612 mld.
+2,26%+5,37%+9,30%+14,09%+26,52%+24,57%+97,69%+166,65%+368,07% 500 mld.
+2,58%+8,31%+9,28%+16,67%+18,80%+37,43%+63,51%+8,93%+66,77% 367 mld.
+3,25%+4,45%-0,80%+19,21%+40,89%+71,80%+44,44%+82,93%+139,50% 354 mld.
+1,85%+5,45%+9,90%+1,20%+15,42%+21,38%+49,26%+64,95%+68,89% 286 mld.
+1,76%+4,92%+0,94%+0,19%-8,50%+0,48%+20,31%+44,39%+155,40% 256 mld.
+3,29%+6,32%+11,64%+20,53%+34,11%+44,71%+57,43%+109,36%+171,79% 230 mld.
+2,25%+5,81%+3,95%+17,49%+27,51%+27,13%+101,17%+134,09%+110,62% 190 mld.
+1,83%+1,87%-7,23%-20,82%-19,69%-23,77%-61,82%-22,03%+89,07% 170 mld.
+2,28%+6,13%+8,54%+21,66%+20,92%+21,95%-1,76%-29,65%-7,47% 168 mld.
+2,53%+6,07%+0,77%+7,11%+13,52%+22,80%+42,22%+177,45%+520,66% 127 mld.
+4,84%+8,84%-1,50%+2,53%+14,35%+41,50%+9,25%+6,22%+22,48% 120 mld.
+1,95%+7,09%+16,20%+23,89%+25,58%+30,76%+127,49%+399,84%+536,07% 118 mld.
+0,73%+5,51%-0,48%-2,50%+2,41%+14,98%+28,76%+6,23%-10,22% 99 mld.
+3,62%+2,77%-0,63%-4,86%-11,05%-14,87%-25,53%-10,95%+7,38% 95,44 mld.
+6,69%+11,94%+39,98%+306,93%+720,89%+788,69%+201,09%-27,31% - 90,58 mld.
+3,25%+7,22%+1,17%+20,13%+4,61%+40,00%-0,12%+43,50%+117,51% 78,09 mld.
+1,42%+5,59%+12,75%+7,41%+19,41%+30,48%-2,43%-24,94%+48,19% 70,41 mld.
Gemiddelde +2,75%+2,18%+4,89%+21,95%+48,89%+64,69%+54,42%+94,77%+323,36% 252,26 mld.
Gewogen gemiddelde per kap. +2,90%+2,40%+5,87%+15,31%+31,64%+48,92%+68,30%+151,95%+468,62%
  1. Beurs
  2. Aandelen
  3. Koers AXSM
  4. Sector Axsome Therapeutics, Inc.